The use of genomic variants to drive drug repurposing for chronic hepatitis B

The use of genomic variants to drive drug repurposing for chronic hepatitis B

Background: One of the main challenges in personalized medicine is to establish and apply a large number of variants from genomic databases into clinical diagnostics and further facilitate genome-driven drug repurposing. By utilizing biological chronic hepatitis B infection (CHB) risk genes, our stu...

Full description

Bibliographic Details
Main Authors: Lalu Muhammad Irham, Wirawan Adikusuma, Dyah Aryani Perwitasari, Haafizah Dania, Rita Maliza, Imaniar Noor Faridah, Ichtiarini Nurullita Santri, Yohane Vincent Abero Phiri, Rocky Cheung
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Biochemistry and Biophysics Reports
Subjects:
Bioinformatics
Chronic hepatitis B
Drug repurposing
Genomic variants
Online Access:http://www.sciencedirect.com/science/article/pii/S2405580822001078

Internet

http://www.sciencedirect.com/science/article/pii/S2405580822001078

Similar Items